| 000 | 01807 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513133938.0 | ||
| 264 | 0 | _c19980209 | |
| 008 | 199802s 0 0 eng d | ||
| 022 | _a0002-9270 | ||
| 024 | 7 |
_a10.1111/j.1572-0241.1998.061_c.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDumot, J A | |
| 245 | 0 | 0 |
_aPretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial. _h[electronic resource] |
| 260 |
_bThe American journal of gastroenterology _cJan 1998 |
||
| 300 |
_a61-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnalgesia |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCholangiopancreatography, Endoscopic Retrograde _xadverse effects |
| 650 | 0 | 4 | _aData Interpretation, Statistical |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylprednisolone _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPancreatitis _xetiology |
| 650 | 0 | 4 | _aParenteral Nutrition |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aSphincter of Oddi _xsurgery |
| 700 | 1 | _aConwell, D L | |
| 700 | 1 | _aO'Connor, J B | |
| 700 | 1 | _aFerguson, D R | |
| 700 | 1 | _aVargo, J J | |
| 700 | 1 | _aBarnes, D S | |
| 700 | 1 | _aShay, S S | |
| 700 | 1 | _aSterling, M J | |
| 700 | 1 | _aHorth, K S | |
| 700 | 1 | _aIssa, K | |
| 700 | 1 | _aPonsky, J L | |
| 700 | 1 | _aZuccaro, G | |
| 773 | 0 |
_tThe American journal of gastroenterology _gvol. 93 _gno. 1 _gp. 61-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1572-0241.1998.061_c.x _zAvailable from publisher's website |
| 999 |
_c9417302 _d9417302 |
||